Suchergebnisse - "JamaliMoghadamSiahkali, SaeidReza"

PubPharm (17)

1

Preparation, characterization and in vitro evaluation of insulin-PHBV nanoparticles / alginate hydrogel composite system for prolonged delivery of insulin

enthalten in: Journal of pharmaceutical sciences | 2024

von Bayrami, S. | Chamani, M. | JamaliMoghadamSiahkali, S. | +9

2

Acupuncture or cupping plus standard care versus standard care in moderate to severe COVID-19 patients : An assessor-blinded, randomized, controlled trial

enthalten in: Integrative medicine research | 2022

von Alipour, R. | Jamalimoghadamsiahkali, S. | Karimi, M. | +4

3

Safety and Effectiveness of High-Dose Vitamin C in Patients with COVID-19; A Randomized Controlled open-label Clinical Trial ‎

enthalten in: ResearchSquare.com | 2022

von JamaliMoghadamSiahkali, S. | Zarezade, B. | Koolaji, S. | +14

4

A case report of prolonged COVID-19-positive RT-PCR for five months

enthalten in: Clinical case reports | 2022

von Siami, Z. | Jamalimoghadamsiahkali, S. | Khavandegar, A.

5

Effect of nanocurcumin supplementation on the severity of symptoms and length of hospital stay in patients with COVID-19 : A randomized double-blind placebo-controlled trial

enthalten in: Phytotherapy research : PTR | 2022

von Honarkar Shafie, E. | Taheri, F. | Alijani, N. | +7

6

Prognostic indicators and outcomes of hospitalised COVID-19 patients with neurological disease : An individual patient data meta-analysis

enthalten in: PloS one | 2022

von Singh, B. | Lant, S. | Cividini, S. | +99

7

A case report of prolonged COVID‐19‐positive RT‐PCR for five months

enthalten in: Clinical Case Reports | 2022

von Siami, Z. | Jamalimoghadamsiahkali, S. | Khavandegar, A.

8

Effect of nanocurcumin supplementation on the severity of symptoms and length of hospital stay in patients with COVID‐19 : A randomized double‐blind placebo‐controlled trial

enthalten in: Phytotherapy Research | 2022

von Honarkar Shafie, E. | Taheri, F. | Alijani, N. | +7

9

Treatment With 25-Hydroxyvitamin D3 (Calcifediol) Is Associated With a Reduction in the Blood Neutrophil-to-Lymphocyte Ratio Marker of Disease Severity in Hospitalized Patients With COVID-19 : A Pilot Multicenter, Randomized, Placebo-Controlled, Double-Blinded Clinical Trial

enthalten in: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists | 2021

von Maghbooli, Z. | Sahraian, M. | Jamalimoghadamsiahkali, S. | +9

10

Efficacy of Persian medicine herbal formulations (capsules and decoction) compared to standard care in patients with COVID-19, a multicenter open-labeled, randomized, controlled clinical trial

enthalten in: Phytotherapy research : PTR | 2021

von Karimi, M. | Zarei, A. | Soleymani, S. | +34